Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Bladder Cancer

  Free Subscription


28.04.2020

1 Aging (Albany NY)
1 AJR Am J Roentgenol
1 Am J Pathol
1 Anaesthesia
1 Arch Biochem Biophys
1 Br J Nutr
1 Cancer Med
1 Clin Genitourin Cancer
1 Clinics (Sao Paulo)
1 Curr Med Res Opin
1 Eur J Pharm Biopharm
1 Eur J Surg Oncol
1 Eur Radiol
1 FASEB J
1 Front Oncol
1 Int J Biol Markers
1 Int J Cancer
2 Int J Clin Oncol
1 Int J Mol Sci
1 Int J Oncol
1 J Cancer
1 J Urol
1 JCO Clin Cancer Inform
1 Jpn J Clin Oncol
1 Mol Med Rep
1 Oncoimmunology
1 Oncol Res Treat
2 Urol Case Rep
2 Urol J
2 Urol Oncol
1 Urology
1 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aging (Albany NY)

  1. YAO K, He L, Gan Y, Liu J, et al
    HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27.
    Aging (Albany NY). 2020;12.
    PubMed         Abstract available


    AJR Am J Roentgenol

  2. TURKBEY B, Czarniecki M, Shih JH, Harmon SA, et al
    Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study.
    AJR Am J Roentgenol. 2020;214:105-113.
    PubMed         Abstract available


    Am J Pathol

  3. MANOCHA U, Kardos J, Selitsky S, Zhou M, et al
    RNA Expression Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder Reveals a Basal-Like Molecular Subtype.
    Am J Pathol. 2020;190:134-144.
    PubMed         Abstract available


    Anaesthesia

  4. LONGDON E, Mistry H, Pratt O, Donnelly A, et al
    Variables associated with survival in patients with invasive bladder cancer with and without surgery.
    Anaesthesia. 2020 Apr 24. doi: 10.1111/anae.15034.
    PubMed         Abstract available


    Arch Biochem Biophys

  5. LI J, Ma W, Cheng X, Zhang X, et al
    Activation of FOXO3 pathway is involved in polyphyllin I-induced apoptosis and cell cycle arrest in human bladder cancer cells.
    Arch Biochem Biophys. 2020 Apr 23:108363. doi: 10.1016/j.abb.2020.108363.
    PubMed         Abstract available


    Br J Nutr

  6. YU EYW, Wesselius A, Sinhart C, Wolk A, et al
    A Data Mining Approach to Investigate Food Groups related to Incidence of Bladder Cancer in the BLadder cancer Epidemiology and Nutritional Determinants International Study.
    Br J Nutr. 2020 Apr 23:1-28. doi: 10.1017/S0007114520001439.
    PubMed         Abstract available


    Cancer Med

  7. HEKTOEN HH, Robsahm TE, Andreassen BK, Stenehjem JS, et al
    Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway.
    Cancer Med. 2020 Apr 21. doi: 10.1002/cam4.3060.
    PubMed         Abstract available


    Clin Genitourin Cancer

  8. TULLY KH, Roghmann F, Noldus J, Chen X, et al
    Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2020 Mar 31. pii: S1558-7673(20)30075.
    PubMed         Abstract available


    Clinics (Sao Paulo)

  9. LUO J, Zhou L, Lin S, Yan W, et al
    Beneficial effect of fluid warming in elderly patients with bladder cancer undergoing Da Vinci robotic-assisted laparoscopic radical cystectomy.
    Clinics (Sao Paulo). 2020;75:e1639.
    PubMed         Abstract available


    Curr Med Res Opin

  10. MALANGONE-MONACO E, Wilson K, Diakun D, Tayama D, et al
    Cost of cystectomy-related complications in patients with bladder cancer in the United States.
    Curr Med Res Opin. 2020 Apr 21:1. doi: 10.1080/03007995.2020.1758927.
    PubMed         Abstract available


    Eur J Pharm Biopharm

  11. ALBERTO BANDEIRA FERREIRA L, Garcia-Fossa F, Radaic A, Duran N, et al
    Biogenic silver nanoparticles: in vitro and in vivo antitumor activity in bladder cancer.
    Eur J Pharm Biopharm. 2020 Apr 17. pii: S0939-6411(20)30106.
    PubMed         Abstract available


    Eur J Surg Oncol

  12. GOEL S, Aggarwal A, Iqbal A, Gupta M, et al
    18-FDG PET-CT should be included in preoperative staging of gall bladder cancer.
    Eur J Surg Oncol. 2020 Apr 15. pii: S0748-7983(20)30412.
    PubMed         Abstract available


    Eur Radiol

  13. WANG H, Xu X, Zhang X, Liu Y, et al
    Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study.
    Eur Radiol. 2020 Apr 21. pii: 10.1007/s00330-020-06796.
    PubMed         Abstract available


    FASEB J

  14. GUO Y, Wang J, Zhou K, Lv J, et al
    Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC.
    FASEB J. 2020 Apr 21. doi: 10.1096/fj.201903266.
    PubMed         Abstract available


    Front Oncol

  15. MACLENNAN SJ, MacLennan S
    How Do We Meet the Supportive Care and Information Needs of Those Living With and Beyond Bladder Cancer?
    Front Oncol. 2020;10:465.
    PubMed         Abstract available


    Int J Biol Markers

  16. WANG J, Wu Y, He W, Yang B, et al
    Nomogram for predicting overall survival of patients with bladder cancer: A population-based study.
    Int J Biol Markers. 2020 Apr 20:1724600820907605. doi: 10.1177/1724600820907605.
    PubMed         Abstract available


    Int J Cancer

  17. HIEN TT, Ambite I, Butler D, Wan MLY, et al
    Bladder cancer therapy without toxicity - A dose-escalation study of alpha1-oleate.
    Int J Cancer. 2020 Apr 22. doi: 10.1002/ijc.33019.
    PubMed         Abstract available


    Int J Clin Oncol

  18. NISHIYAMA H, Yamamoto Y, Sassa N, Nishimura K, et al
    Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial.
    Int J Clin Oncol. 2020;25:165-174.
    PubMed         Abstract available

  19. YAO Z, Jiang Y, Zhu X, Wu B, et al
    Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study.
    Int J Clin Oncol. 2020 Apr 21. pii: 10.1007/s10147-020-01679.
    PubMed         Abstract available


    Int J Mol Sci

  20. KIM H, Lee SJ, Lee IK, Min SC, et al
    Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available


    Int J Oncol

  21. ZHANG HH, Huang ZX, Zhong SQ, Fei KL, et al
    miR21 inhibits autophagy and promotes malignant development in the bladder cancer T24 cell line.
    Int J Oncol. 2020 Feb 13. doi: 10.3892/ijo.2020.4984.
    PubMed         Abstract available


    J Cancer

  22. PENG T, Wang G, Cheng S, Xiong Y, et al
    The role and function of PPARgamma in bladder cancer.
    J Cancer. 2020;11:3965-3975.
    PubMed         Abstract available


    J Urol

  23. ROUPRET M, Gontero P, McCracken SRC, Dudderidge T, et al
    Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Non Muscle Invasive Bladder Cancer Follow up: A Blinded, Prospective Cohort, Multicentric European Study.
    J Urol. 2020 Apr 21:101097JU0000000000001084. doi: 10.1097/JU.0000000000001084.
    PubMed         Abstract available


    JCO Clin Cancer Inform

  24. HARMON SA, Sanford TH, Brown GT, Yang C, et al
    Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer.
    JCO Clin Cancer Inform. 2020;4:367-382.
    PubMed         Abstract available


    Jpn J Clin Oncol

  25. MATSUSHITA Y, Watanabe K, Watanabe H, Tamura K, et al
    Second transurethral resection for high-risk non-muscle invasive bladder cancer patients: a propensity score matched analysis.
    Jpn J Clin Oncol. 2020 Apr 23. pii: 5823898. doi: 10.1093.
    PubMed         Abstract available


    Mol Med Rep

  26. TAN QL, Zhou CY, Cheng L, Luo M, et al
    Immunotherapy of Bacillus CalmetteGuerin by targeting macrophages against bladder cancer in a NOD/scid IL2Rg/ mouse model.
    Mol Med Rep. 2020 Apr 22. doi: 10.3892/mmr.2020.11090.
    PubMed         Abstract available


    Oncoimmunology

  27. WANG Z, Zhou Q, Zeng H, Zhang H, et al
    Tumor-infiltrating IL-17A(+) cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer.
    Oncoimmunology. 2020;9:1747332.
    PubMed         Abstract available


    Oncol Res Treat

  28. MANI J, Neuberth MT, Fettel J, Senf B, et al
    Quality of Patient Information by Urologists Is Associated with Mental Distress in Bladder Cancer Patients.
    Oncol Res Treat. 2020 Apr 21:1-8. doi: 10.1159/000507094.
    PubMed         Abstract available


    Urol Case Rep

  29. BALOGLU IH, Albayrak AT, Gunay KC, Yavuzsan AH, et al
    Regression of the Sweet's syndrome after Bacillus Calmette-Guerin therapy: A bladder cancer case report.
    Urol Case Rep. 2020;31:101202.
    PubMed         Abstract available

  30. BHAKTA PS, Harris EA, Connolly MM
    A patient with history of bladder cancer presenting with an axillary mass: A rare case of supradiaphragmatic cutaneous bladder cancer metastasis.
    Urol Case Rep. 2020;31:101157.
    PubMed         Abstract available


    Urol J

  31. BAHRAMI S, Gheysarzadeh A, Sotoudeh M, Bandehpour M, et al
    The Association Between Gelsolin-like Actin-capping Protein (CapG) Overexpression and Bladder Cancer Prognosis.
    Urol J. 2020 Apr 20. pii: 5664/1466. doi: 10.22037/uj.v0i0.5664.
    PubMed         Abstract available

  32. XUE M, Liu L, Du G, Fu Z, et al
    Diagnostic Evaluation of 18F-FDG PET/CT Imaging in Recurrent or Residual Urinary Bladder Cancer: A Meta-Analysis.
    Urol J. 2020 Apr 20. pii: 5538/1462. doi: 10.22037/uj.v0i0.5538.
    PubMed         Abstract available


    Urol Oncol

  33. BENLIER N, Solakhan M, Yildirim Z, Kaya V, et al
    A novel diagnostic tool for the detection of bladder cancer: Measurement of urinary high mobility group box-1.
    Urol Oncol. 2020 Apr 17. pii: S1078-1439(20)30131.
    PubMed         Abstract available

  34. SANCHEZ A, Kissel S, Coletta A, Scott J, et al
    Impact of body size and body composition on bladder cancer outcomes: Risk stratification and opportunity for novel interventions.
    Urol Oncol. 2020 Apr 18. pii: S1078-1439(20)30104.
    PubMed         Abstract available


    Urology

  35. PEARD L, Stark T, Ziada A, Saltzman AF, et al
    Recurrent Bladder Cancer in a Teenage Male.
    Urology. 2020 Apr 22. pii: S0090-4295(20)30411.
    PubMed         Abstract available


    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

  36. LI W, Zeng J, Luo B, Mao Y, et al
    [High expression of activated CD4(+) memory T cells and CD8(+) T cells and low expression of M0 macrophage are associated with better clinical prognosis in bladder cancer patients].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020;36:97-103.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: